Ziva DRA supports pharmaceutical, biotechnology, medical-device and healthcare companies with clinical research planning, regulatory coordination, study-documentation support and project management for clinical trial activities in Bangladesh.
Clinical research projects involve multiple interconnected requirements. Study design, protocol documentation, regulatory activities, research sites, sponsor responsibilities and study execution all need to be coordinated carefully.
Ziva DRA supports clients by helping structure the clinical project, identify relevant documentation and regulatory requirements, coordinate research activities and maintain visibility across the engagement.
Clinical trial support can also connect with pharmacovigilance, bioanalytics, BA/BE studies, medicine registration and broader regulatory services depending on the development program.
Each research project requires a study-specific scope. Depending on the program, Ziva DRA may support the following workstreams.
Review the study objective, development stage, product profile and practical research requirements.
Support assessment and organization of relevant clinical study documentation.
Support preparation and coordination of applicable regulatory and ethics workstreams.
Support project coordination with relevant institutions and research sites where applicable.
Help coordinate project milestones, documentation and communication across the study.
Support relevant study documentation, safety and research compliance requirements.
A structured workflow helps align regulatory, documentation and operational study activities.
Clarify study objective and development requirement.
Review feasibility, documentation and regulatory scope.
Organize study and regulatory documentation.
Support study sites and relevant project workstreams.
Maintain project and compliance coordination.
Study-specific documentation and compliance requirements should be reviewed before clinical activities begin.
A clear project profile helps define the appropriate support and coordination model.
The documentation package should be defined against the specific study and applicable requirements.
Sponsors and manufacturers undertaking pharmaceutical clinical development activities.
Biotechnology organizations planning research and development programs.
Device companies requiring clinical research or evidence-generation support.
Overseas organizations requiring Bangladesh-focused research and regulatory coordination.
Yes. Ziva DRA can support overseas sponsors and companies requiring Bangladesh-focused clinical and regulatory coordination.
No. Requirements depend on the study design, investigational product, protocol, sites and applicable regulatory and ethics requirements.
Yes. An initial review can help define the likely documentation and coordination scope.
Yes. Where relevant, clinical research, BA/BE, bioanalytics and regulatory workstreams can be coordinated within the broader development program.
Share the study objective, product profile, protocol status and available documentation with Ziva DRA so the appropriate research and regulatory support scope can be assessed.